Mirae Asset Global ETFs Holdings
CTKB icon

Mirae Asset Global ETFs Holdings’s Cytek Biosciences CTKB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
56,017
+872
+2% +$3.72K ﹤0.01% 2373
2026
Q1 		$241K Buy
55,145
+534
+1% +$2.52K ﹤0.01% 2256
2025
Q4 		$276K Sell
54,611
-644
-1% -$2.99K ﹤0.01% 2191
2025
Q3 		$192K Sell
55,255
-9,135
-14% -$34.3K ﹤0.01% 2342
2025
Q2 		$219K Sell
64,390
-6,224
-9% -$20.7K ﹤0.01% 2235
2025
Q1 		$283K Buy
70,614
+1,540
+2% +$7.98K ﹤0.01% 2134
2024
Q4 		$448K Buy
69,074
+2,373
+4% +$14.1K ﹤0.01% 1978
2024
Q3 		$370K Buy
66,701
+4,875
+8% +$27.6K ﹤0.01% 2068
2024
Q2 		$345K Buy
+61,826
New +$371K ﹤0.01% 1988

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CTKB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Cytek Biosciences (CTKB) stake by 1.6% in Q2 2026, buying an estimated $3.72K and bringing the position to 56,017 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #2373.

Mirae Asset Global ETFs Holdings first reported a position in CTKB in Q2 2024 and has held it in 9 quarters since. The position peaked at $448K in Q4 2024. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 56,017 shares of Cytek Biosciences worth $248K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 872 Cytek Biosciences shares in Q2 2026, an estimated $3.72K.
  • Cytek Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2373 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Cytek Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Cytek Biosciences position peaked at $448K in Q4 2024.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.